重组腺相关病毒(rAAV)载体介导的抗体基因治疗药物,可为宿主直接提供中和抗体而使其免受艾滋病毒感染,有望成为艾滋病预防及治疗疫苗的替代品。综述人免疫缺陷病毒(HIV)专属性广谱中和抗体发现过程的文献资料,介绍了rAAV介导的抗HIV抗体基因治疗的试验结果,并对rAAV在艾滋病预防及治疗的研究进展作了分析。
Recombinant adeno-associated virus (rAAV) vector mediated antibody gene therapy medicine, that can provide neutralizing antibodies to the host for protection from HIV infection against infection, is an alternative of HIV vaccine. The literatrue on the progress in isolation of HIV specific broadly neutralizing antibodies(bNAbs), rAAV mediated bnAb gene therapy experiments against HIV is reviewed. The rAAV mediated gene therapy for HIV antibody test results have been introduced, and its research advances have been analyzed.